Skip to main content

CDTX

Stock
Health Care
Biotechnology

Performance overview

CDTX Price
Price Chart

Forward-looking statistics

Beta
1.11
Risk
78.24%

Detailed forecast

[disclaimer]

Individual forecast components (weighted-sum)

Company Profile

Cidara Therapeutics Inc is developing immunotherapeutics designed to help improve the standard of care for patients facing serious diseases. The Company's portfolio comprises new approaches aimed at transforming existing treatment and prevention paradigms, including DFCs from its proprietary Cloudbreak platform targeting oncologic, viral and autoimmune diseases.

Company info

SectorHealth Care
IndustryBiotechnology
Employees77
Market cap$58.6M

Fundamentals

Enterprise value$466.3M
Revenue$302.0K
Revenue per employee—
Profit margin0.00%
Debt to equity1.89

Security info

ExchangeNASDAQ
Type of shareCommon Stock
Earnings per share (EPS)-$26.68
Dividend per share—
Revenue per share$0.03
Avg trading volume (30 day)$47M
Avg trading volume (10 day)$121M
Put-call ratio—

Macro factor sensitivity

Growth-4.0
Credit+7.0
Liquidity+3.0
Inflation-5.5
Commodities-2.1
Interest Rates-2.7

Valuation

Dividend yield0.00%
PEG Ratio-6.25
Price to sales3379.78
P/E Ratio-6.25
Enterprise Value to Revenue1543.98
Price to book4.20

Upcoming events

Next earnings dayMay 9, 2025
Next dividend day—
Ex. dividend day—

News

Why Is Cidara Therapeutics Stock Trading Higher On Monday?

Cidara Therapeutics, Inc. CDTX stock is trading over 90% higher on Monday with a session volume of 3.2 million compared to the average volume of 181.7K.

Benzinga (June 23, 2025)
Are You Looking for a Top Momentum Pick? Why Cidara Therapeutics (CDTX) is a Great Choice

Does Cidara Therapeutics (CDTX) have what it takes to be a top stock pick for momentum investors? Let's find out.

Zacks Investment Research (April 30, 2025)

Unlock Personalized Financial Tools

All our core financial tools are completely free. Create an account to save your research, get personalized recommendations, and enjoy unlimited access.

Save research to draft portfolios
Get personalized recommendations
Access unlimited tool usage
Sign up for free